Boundless Bio, Inc.
NASDAQ: BOLD. Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors.
US
- Alpha ID
- alpha:company:a911dffa-e2bf-4f59-b645-fa6feb53880b
- SEC CIK
- 0001782303
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- Apr 29, 2025
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Not published
- Chair
- Not published
- Independent
- 5 / 77 directors published
- Published claims
- 192 distinct sources
- Evidence records
- 30 pinned
- Source conflicts
- 0None open
Built from 2 distinct sources and 3 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
James Christensen, Ph.D. seat on Boundless Bio, Inc., effective 2023-01-01.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Board of directors
Evidence7 directors published. 5 of 7 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Christine Brennan, Ph.D. | Independent | 2022 | None published | Source reportedE2 |
| James Christensen, Ph.D. | Independent | 2023 | None published | Source reportedE2 |
| Jennifer Lew | Independent | 2022 | Audit, chairAudit · Chair; CompensationCompensation | Source reportedE2 |
| Jonathan E. Lim, M.D. | Not independent | 2018 | None published | Source reportedE2 |
| Kristina Burow | Independent | 2019 | AuditAudit; CompensationCompensation | Source reportedE2 |
| Nancy Whiting, Pharm.D. | Independent | 2023 | None published | Source reportedE2 |
| Zachary D. Hornby | Not independent | 2019 | None published | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Jennifer Lew | Jennifer Lew, Kristina Burow | Not described in the published record |
| Audit · Chair; Compensation | Not published | Jennifer Lew | Not described in the published record |
| Audit; Compensation | Not published | Kristina Burow | Not described in the published record |
| Compensation | Not published | Jennifer Lew, Kristina Burow | Not described in the published record |
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
EvidenceGovernance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- LeadershipNot reviewed. Executive leadership carries operating authority.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Christine Brennan, Ph.D.Directorcompany:a911dffa-e2bf-4f59-b645-fa6feb53880b:leadership_role:7
- James Christensen, Ph.D.Directorcompany:a911dffa-e2bf-4f59-b645-fa6feb53880b:leadership_role:8
- Jennifer LewDirectorcompany:a911dffa-e2bf-4f59-b645-fa6feb53880b:leadership_role:9
- Jonathan E. Lim, M.D.Directorcompany:a911dffa-e2bf-4f59-b645-fa6feb53880b:leadership_role:10
- Kristina BurowDirectorcompany:a911dffa-e2bf-4f59-b645-fa6feb53880b:leadership_role:11
- Nancy Whiting, Pharm.D.Directorcompany:a911dffa-e2bf-4f59-b645-fa6feb53880b:leadership_role:12
- Zachary D. HornbyDirectorcompany:a911dffa-e2bf-4f59-b645-fa6feb53880b:leadership_role:13
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 3 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 6 Claims.
- E2sec proxy. Published Apr 29, 2025. Retrieved Apr 28, 2026. Cited by 7 Claims.
- E3board_seats. board seats. Cited by 6 Claims.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- James Christensen, Ph.D. seat on Boundless Bio, Inc., effective 2023-01-01.
- Nancy Whiting, Pharm.D. seat on Boundless Bio, Inc., effective 2023-01-01.
- Christine Brennan, Ph.D. seat on Boundless Bio, Inc., effective 2022-01-01.
- Jennifer Lew seat on Boundless Bio, Inc., effective 2022-01-01.
- Audit · Chair; Compensation committee of Boundless Bio, Inc., effective 2022-01-01.
- Jennifer Lew member of Audit · Chair; Compensation, effective 2022-01-01.
- Kristina Burow seat on Boundless Bio, Inc., effective 2019-01-01.
- Zachary D. Hornby seat on Boundless Bio, Inc., effective 2019-01-01.
- Audit; Compensation committee of Boundless Bio, Inc., effective 2019-01-01.
- Kristina Burow member of Audit; Compensation, effective 2019-01-01.
- Jonathan E. Lim, M.D. seat on Boundless Bio, Inc., effective 2018-01-01.



